S3 heart sound detection
 
Missions
Technology
Products
Media Room

Inovise Corporate
Management Team
History/Vision
Careers

Board of Directors

David A. Chazanovitz, Chair
Mr. Chazanovitz is President and CEO Alveolus, Inc., a leader in the development of non-vascular interventional stent technology. He served as Chief Executive Officer of Cambridge Heart, Inc. from 2001 through October 2006 and as Chairman of the Board of Directors from July 2004 to October 2006. From 1998 to September 2000, Mr. Chazanovitz served as the President of the Neurosciences Division of NMT Medical Inc.. From 1996 to July 1998, Mr. Chazanovitz served as the President of the Septal Repair Division of NMT, following the merger of Innerventions, Inc. with NMT. Mr. Chazanovitz was a founder in 1995 of Innerventions, a developer of septal repair devices. Mr. Chazanovitz also previously served as the President of several divisions of C.R. Bard, Inc., including Bard Ventures, Bard Electrophysiology and USCI Angiography. He also serves as a member of the Board of Directors of MedicalCV, Inc (OTCBB:MCVI).

Dallas Ross
Mr. Ross is a partner and founder of Kinetic Capital Partners, a private equity and late stage venture capital firm started in 2001 with substantial high net worth equity backers. Kinetic Capital Partners invests in selected healthcare, information system and consumer businesses. Previously, Mr. Ross was Managing Director, Investment Banking and prior to that Managing Director, Mergers and Acquisitions at Scotia Capital Markets where he commenced employment in Toronto in 1985. Mr. Ross is currently active on the board of six organizations: two are public companies; three are private companies; and one is a not-for-profit institution. He has an honors business degree from the University of British Columbia and subsequent to that qualified as a Chartered Accountant.

Peter Bauer
Prior to leading the company, Peter Bauer was the Vice President of Technology at Inovise Medical for over 6 years and held multiple Director positions in the area of Research and Development at BIOTRONIK for 8 years. Bauer began working in the biomedical industry in 1995 after working many years in several research facilities in Europe in the area of solid state physics, surface science, and nanotechnology. He holds a Ph.D. in Physics from the University of Erlangen-Nuremberg, Germany.